News

Under the terms of the agreement, Albany Molecular Research (AMRI) will manufacture the active pharmaceutical ingredient in New River’s NRP104, an investigational treatment for ADHD that is currently

The amendment extends the exclusive option agreement an additional year and will expire on December 6, 2007 beyond the anticipated date of a new drug application (NDA) filing

Genzyme is also currently conducting approval-qualifying manufacturing runs of Cerezyme and Myozyme at the facility. Myozyme, which is currently manufactured in the US, was approved this year in

NGX267, a selective cholinergic muscarinic, or M1, receptor agonist, has demonstrated potential in providing both symptomatic improvement and disease modification in animal models of Alzheimer’s disease. This second

Patients were evaluated while receiving either placebo or one of three dose levels of arimoclomol three times daily for 12 weeks and during a 4-week follow-up period without

CDA (chlorproguanil hydrochloride-dapsone-artesunate) is being developed as a fixed-dose combination to meet the urgent need for new malaria treatments in the developing world where multi-drug resistance is contributing

Consequently, the company said that it will not include an FTC approval condition in the formal tender offer it intends to file with the Croatian Financial Services Supervisory

The interim analysis demonstrated a clear positive trend toward efficacy, with 61% (33 of 54) of patients receiving RSD1235 completing the study with normal heart rhythm, as compared

The Nexavar approval is specifically for the treatment of patients with advanced renal cell carcinoma who have failed prior interferon- alpha or interleukin-2 based therapy or are considered